all report title image

CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS

Continuous Renal Replacement Therapy Market, By Product Type (Dialysate and Replacement Fluids, Disposables, Bloodline Sets, and Hemofilters System), By Modality (Slow Continuous Ultrafiltration, Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, and Continuous Venovenous Hemodiafiltration), By End User (Hospitals and Dialysis Clinics) - Global Industry Insights, Outlook And Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI1051
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Leading Companies

Innovative Multifiltrate PRO launched by Fresenius Medical care AG &Co. KGaA to boost the growth of continuous renal replacement therapy market

The key players in the continuous renal replacement therapy market are Baxter International, Nikkiso Co. Ltd., B. Braun Melsungen AG, Bellco S.r.I, NxStage Medical, Asahi Kasei Corporation, Medica S.P.A, Toray Medical Co., Nipro Corporation, Medtronic Plc, and Dialysis Solutions Inc. The key players are focusing on strategic mergers and acquisition and development of innovative therapy systems. For instance, Fresenius Medical Care AG & Co. KGaA, in May 2015, launched a new therapy system named Multifiltrate PRO for continuous renal replacement therapy and also for the acute kidney failure.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.